K163357

Substantially Equivalent

OneTouch Via On-Demand Insulin Delivery System

Applicant: Lifescan Europe, A Division of Cilag GmbH
Product code: OPP
Advisory panel: General Hospital
Date received: 2016-11-30
Decision date: 2017-06-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Zug, CH

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.